Central U.S. Manufacturing Activity Declines Further in March — Kansas Fed
By Ed Frankl
Factory activity in the central U.S. declined at a quicker pace in March, as demand continues to struggle in the manufacturing sector.
The Federal Reserve Bank of Kansas City said Thursday that the Tenth District manufacturing survey's composite index was minus seven in March, dipping from minus four in February.
The reading was weaker than expectations of the index to rise to minus 3, according to a consensus of economists polled by The Wall Street Journal. Any reading below zero suggests activity contracted from the previous month.
The Kansas City Fed survey gauges manufacturing activity in the western third of Missouri, all of Kansas, Colorado, Nebraska, Oklahoma and Wyoming, and the northern half of New Mexico.
Production and volume of shipments ticked down, while both new orders and backlogs fell sharply, the Kansas City Fed said. Primary metal, electrical equipment, and paper manufacturing drove the decrease in the index, it said.
Meanwhile, prices grew at a similar rate to previous months, while employment levels continued to rise, the Kansas City Fed added.
Last year "finished with much higher bookings and shipments than 2022, but orders in the first quarter of 2024 have slowed substantially," said one respondent from the manufacturing sector.
While activity dipped further in March, expectations for future output were steady, said Chad Wilkerson, senior vice president at the Kansas City Fed.
Write to Ed Frankl at edward.frankl@wsj.com
(END) Dow Jones Newswires
March 28, 2024 11:31 ET (15:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth